Nav: Home

Algorithm turns cancer gene discovery on its head

January 20, 2020

A method for finding genes that spur tumor growth takes advantage of machine learning algorithms to sift through reams of molecular data collected from studies of cancer cell lines, mouse models and human patients.

By teaching the artificial intelligence system to link certain DNA mutations to altered functionality, a team led by Robert Hoehndorf from KAUST's Computational Bioscience Research Center showed that they could identify genes with a known causative role in cancer and pick out dozens of putative new ones for 20 different tumor types.

The prediction method--described in Scientific Reports and freely available online--could help clinicians tailor medicines to the molecular subtypes of patients. It could also be used by drug companies in the hunt for new therapeutic targets.

"Our method can be used as a framework to predict and validate cancer-driver genes in any database or real population sample," says Sara Althubaiti, a Ph.D. student in Hoehndorf's lab and the first author of the study.

Traditionally, scientists have approached the search for genes with a causal role in cancer by starting with DNA sequence data. By extensively cataloging tumor mutations shared among patients with a common type of cancer, the research community has documented hundreds of genes with a causal impact on tumor development. Experimental follow up is then used to functionally associate these genes with the hallmarks of cancer.

"Our method turns this approach on its head," Althubaiti explains. "Essentially, our approach is knowledge-driven and we use tumor sequencing data as validation. This is unlike most approaches, which are data-driven combined with interpretation of the findings with respect to established knowledge."

The rate of discovery for new cancer-driving genes has been declining rapidly in recent years, leading the KAUST team to seek a new computational strategy. Instead of relying on sequence data, Althubaiti and Hoehndorf built a machine learning model that takes into account many biological features of genes and pathways involved in tumor formation.

The researchers designed the algorithm to recognize functional and phenotypic patterns that predispose a gene toward playing a role in driving tumor development. They validated the model using a publicly available database of some 27,000 different tumor variants as well as functional and sequence data--showing that the algorithm could accurately categorize known cancer-driving genes and detect more than 100 other likely culprits, many with specific roles in particular tumor types.

The KAUST investigators then further tested the algorithm's performance on molecular data gathered from two cohorts of cancer patients. The first was from King Abdulaziz University Hospital in Saudi Arabia, comprising 26 tumor samples from individuals with a rare type of head and neck cancer called nasopharyngeal carcinoma. The other cohort comprised 114 colorectal cancer samples from patients treated at the University of Birmingham Hospital in the United Kingdom. In both patient groups, the model singled out candidate driver genes that were frequently mutated and shared pathogenic features of other cancer-causing genes.

Hoehndorf emphasizes the importance of the team effort involved. "This work is a good example for scientific collaboration within Saudi Arabia," he says, "but it also demonstrates the need for multidisciplinary collaborations between computer scientists, clinical researchers and biologists."
-end-


King Abdullah University of Science & Technology (KAUST)

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Our Relationship With Water
We need water to live. But with rising seas and so many lacking clean water – water is in crisis and so are we. This hour, TED speakers explore ideas around restoring our relationship with water. Guests on the show include legal scholar Kelsey Leonard, artist LaToya Ruby Frazier, and community organizer Colette Pichon Battle.
Now Playing: Science for the People

#568 Poker Face Psychology
Anyone who's seen pop culture depictions of poker might think statistics and math is the only way to get ahead. But no, there's psychology too. Author Maria Konnikova took her Ph.D. in psychology to the poker table, and turned out to be good. So good, she went pro in poker, and learned all about her own biases on the way. We're talking about her new book "The Biggest Bluff: How I Learned to Pay Attention, Master Myself, and Win".
Now Playing: Radiolab

Uncounted
First things first: our very own Latif Nasser has an exciting new show on Netflix. He talks to Jad about the hidden forces of the world that connect us all. Then, with an eye on the upcoming election, we take a look back: at two pieces from More Perfect Season 3 about Constitutional amendments that determine who gets to vote. Former Radiolab producer Julia Longoria takes us to Washington, D.C. The capital is at the heart of our democracy, but it's not a state, and it wasn't until the 23rd Amendment that its people got the right to vote for president. But that still left DC without full representation in Congress; D.C. sends a "non-voting delegate" to the House. Julia profiles that delegate, Congresswoman Eleanor Holmes Norton, and her unique approach to fighting for power in a virtually powerless role. Second, Radiolab producer Sarah Qari looks at a current fight to lower the US voting age to 16 that harkens back to the fight for the 26th Amendment in the 1960s. Eighteen-year-olds at the time argued that if they were old enough to be drafted to fight in the War, they were old enough to have a voice in our democracy. But what about today, when even younger Americans are finding themselves at the center of national political debates? Does it mean we should lower the voting age even further? This episode was reported and produced by Julia Longoria and Sarah Qari. Check out Latif Nasser's new Netflix show Connected here. Support Radiolab today at Radiolab.org/donate.